Molecular programs of fibrotic change in aging human lung.
Seoyeon J LeeMohammad Naimul IslamKaveh BoostanpourDvir AranGuangchun JinStephanie ChristensonMichael A MatthayWalter L EckalbarDaryle J DePiantoJoseph R ArronLiam MageeSunita BhattacharyaRei MatsumotoMasaru KubotaDonna L FarberJahar BhattacharyaPaul J WoltersMallar BhattacharyaPublished in: Nature communications (2021)
Lung fibrosis is increasingly detected with aging and has been associated with poor outcomes in acute lung injury or infection. However, the molecular programs driving this pro-fibrotic evolution are unclear. Here we profile distal lung samples from healthy human donors across the lifespan. Gene expression profiling by bulk RNAseq reveals both increasing cellular senescence and pro-fibrotic pathway activation with age. Quantitation of telomere length shows progressive shortening with age, which is associated with DNA damage foci and cellular senescence. Cell type deconvolution analysis of the RNAseq data indicates a progressive loss of lung epithelial cells and an increasing proportion of fibroblasts with age. Consistent with this pro-fibrotic profile, second harmonic imaging of aged lungs demonstrates increased density of interstitial collagen as well as decreased alveolar expansion and surfactant secretion. In this work, we reveal the transcriptional and structural features of fibrosis and associated functional impairment in normal lung aging.
Keyphrases
- dna damage
- systemic sclerosis
- endothelial cells
- idiopathic pulmonary fibrosis
- genome wide
- multiple sclerosis
- public health
- anti inflammatory
- oxidative stress
- gene expression
- minimally invasive
- type diabetes
- dna repair
- transcription factor
- lps induced
- inflammatory response
- adipose tissue
- machine learning
- liver fibrosis
- insulin resistance
- liquid chromatography tandem mass spectrometry
- induced pluripotent stem cells
- glycemic control
- skeletal muscle
- photodynamic therapy
- pluripotent stem cells
- wound healing